Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Allara Health vs PauseRX

Allara Health
Graded #95

Higher grade

vs+2.700000000000003
PauseRX
Graded #147

Lower grade

The verdict

Allara Health takes it — 71.2/100 to 68.5/100.

Allara Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Allara Health (allarahealth.com) is an insurance-accepting telehealth platform focused on women's metabolic and hormonal health, including PCOS, serving 44 states plus DC.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAllara Health +2
68
66
Dose & formulationPauseRX +9
76
85
Clinical oversightAllara Health +2
85
83
Labs & monitoringAllara Health +9
61
52
FulfillmentAllara Health +9
70
61
Contract termsAllara Health +14
55
41
Allara Health · left barPauseRX · right bar

The numbers

MetricAllara HealthPauseRX
WeighScore71.2/10068.5/100
GradeCC
Scorecard rank#95#147
Semaglutide$149/mo (plus a separate fee, brand-name)$199/mo
TirzepatideNot disclosed$249/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesInjection only
Allara Health

Graded #95 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound)
  • Accepts insurance with self-pay option from $149/month
  • Women's-health and PCOS specialization with hormonal/metabolic testing
  • Board-certified physicians, OB-GYNs, endocrinologists, plus dietitians
  • Oral alternatives (Metformin, Contrave, Topiramate) available

Where it loses points

  • Membership covers visits; GLP-1 medication coverage depends on your plan
  • Not available in all states for medical care
  • Focused on women's health, not a general GLP-1 provider
  • Out-of-pocket branded GLP-1 cost can be high if not insurance-covered
PauseRX

Graded #147 · C

Strengths

  • Names its 503A pharmacy partner (Strive Pharmacy, Gilbert AZ) — buyers can independently verify its licensure
  • Names its physician network (Beluga Health) — you can research the clinical platform handling your prescriptions
  • Publishes the FDA compounded-medication disclaimer
  • Corporate legal entity disclosed (PauseRX, Inc.) — uncommon for direct-to-consumer GLP-1 platforms
  • Flat $199 'all doses' compounded semaglutide pricing — no per-tier escalation

Where it loses points

  • States served not listed — site claims nationwide, but you must contact support to confirm availability
  • Restrictive cancellation policy — orders can't be changed or canceled once submitted, and medications can't be returned
  • No named medical director (Beluga Health is the network, not a named MD)
  • LegitScript certification number not shown — badge only, so no direct lookup
  • Insurance not accepted — cash-pay only; HSA/FSA eligibility not confirmed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard